MHY5396 treatment significantly reduced the expression of inflammation‐related genes (Ccl2, Ccl5, and Cxcl1) and macrophage markers (Emr1 and Cd163) compared with the FA group (Figure 7A,B). Here, CXCL1 is linked to Friedreich ataxia.